Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
europe blog main
europe top stories
3
×
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amag pharmaceuticals
boston top stories
cancer immunotherapy
clinical trials
covid-19
deals
deerfield management
What
bio
roundup
covid
ipo
medicines
acquisitions
activity
alliance
announced
approvals
biogen
bristol
buy
calls
ceo
changing
clamped
collabs
color
crispr
daniel
days
deal
delays
developing
economic
fast
fda
gilead
gilead’s
growing
help
hours
including
introduce
isn’t
kudos
leaves
lot
month
Language
unset
Current search:
cancer
×
biogen
×
" europe top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More